In a perfect world patients enrolled in clinical trials would live a short distance from the investigator site where they receive their treatment. Unfortunately that is not always the case.
Thermo Fisher Scientific now provides scalable and enhanced direct-to-patient services that ensure patients receive their medication safely and on time in 46+ countries. Our proven expertise starting with Clinical Ancillary and Comparator drug sourcing; primary and secondary packaging, new and enhanced direct-to-patient services, and dedicated staff enable you to focus on furthering your discoveries and helping more patients.
Download this case study to learn how Thermo Fisher Scientific was able to provide Direct-to-Patient services to meet a critical need.